
Overview
Background
Mariusz Skwarczynski completed his Ph.D. in Chemistry in 1999 at Wroclaw University of Technology (Poland). His postdoctoral training began at Tokushima Bunri University (Japan) under the direction of late Professor M. Nishizawa, where he studied the biomimetic total synthesis of anticancer agent paclitaxel. He then joined the laboratory of Professor Yoshiaki Kiso at Kyoto Pharmaceutical University (Japan) to study prodrugs of paclitaxel. In 2004 he was awarded with Japanese fellowship (Japan Society for the Promotion of Science postdoctoral fellowship) and research grant to conduct further research on paclitaxel. He developed novel classes of paclitaxel prodrugs: isotaxoids and phototaxels. He also co-developed an epimerization-free method for the synthesis of novel building blocks (isodipeptides) for solid phase peptide synthesis and these units have been commercialized by Merck-Novabiochem.
In 2008 he joined Professor Istvan Toth group at University of Queensland (Australia) to work on vaccine delivery strategies. Since then, he research is mainly focused on nanotechnology-based peptide vaccine delivery approaches. In 2010 he was awarded with University of Queensland Strategic Fund Research Fellowship. In Australia, he is involved in a wide range of collaborative research projects, both nationally and internationally, to develop vaccines against GAS, HIV, hookworm infections, malaria and cancer, along with antibiotics against multidrug resistant bacteria.
Availability
- Associate Professor Mariusz Skwarczynski is:
- Available for supervision
- Media expert
Fields of research
Qualifications
- Masters (Coursework) of Science, Wroclaw University of Technology
- Doctor of Philosophy, Wroclaw University of Technology
- Member, Australian Infectious Diseases Research Centre, Australian Infectious Diseases Research Centre
- Journal Editorial Board Member, Current Drug Delivery, Current Drug Delivery
- Journal Editorial Board Member, Frontiers in Pharmacology (Associate Editor), Frontiers in Pharmacology (Associate Editor)
- Journal Editorial Board Member, Medicinal Chemistry, Medicinal Chemistry
- Member, Royal Australian Chemical Institute, Royal Australian Chemical Institute
- Member, The Japan Society for the Promotion of Science Alumni Association in Australia, The Japan Society for the Promotion of Science Alumni Association in Australia
- Journal Editorial Board Member, Vaccines (Regional Editor of Australia), Vaccines (Regional Editor of Australia)
Research interests
-
Vaccines and Nanomedicine
Vaccine Desing, Nanotechnology, Peptide Chemistry, Medicinal Chemistry, Vaccine/Drug Delivery, Antimicrobial Agents, Macromolecules, Adjuvants, Immunology
Research impacts
Mariusz Skwarczynski has over 180 publications, including peer-reviewed journals, book chapters (Wiley, Springer Nature, Nova Science, Elsevier), and two edited book (Elsevier, Springer Nature) – as of 2023. Among these publications, 16 are in journals with an impact factor of 10-30. He was ranked 3rd in the world in the Subunit Vaccines field (2012-2022) by Expertscape's PubMed-based scheme and placed among the top 0.1% (0.022% of 18,308 published authors) of scholars writing about Subunit Vaccines over the past 10 years: https://expertscape.com/ex/vaccines%2C+subunit. He is an inventor on three patents that attracted interest from the industry including Meat & Livestock Australia Ltd, Vet-Agro Sp. z o.o., Paragen Bio, and Brandon Capital. He co-developed an epimerization-free method for the synthesis of novel building blocks (isodipeptides) for solid-phase peptide synthesis; these units have been commercialised by Merck-Novabiochem. Recently, he has been actively engaged in several projects aimed at the commercialisation of veterinary vaccines (mostly targeting domestic and wild animals’ fertility control) in Australia and Italy.
He is very active in a collaborative initiative between universities, on projects to develop vaccines against Group A Streptococcus, tuberculosis, hookworm, malaria, porcine circovirus, babesia and cancer, as well as other drug delivery systems. He is an Associate Editor in Frontiers in Pharmacology, (2016 – current) and Regional Editor of Australia in Vaccines (2018 – current). In addition to grants from the ARC and NHMRC, he is also the recipient of industry-specific grants (Economic Accelerator Launch Programme 2023 and Meat & Livestock Australia Limited grant 2021). He regularly communicates with the public (locally and internationally) on issues related to vaccine development and safety. His recent publication on the oral hookworm vaccine has attracted wide media interest from all over the world (Australia, India, China, Kenya, New Zealand, Hungary, Pakistan, etc.). He is often invited to present at international conferences, and recently he organised and chaired Micro and Nanoparticles in Drug and Vaccine Delivery Symposium, Brisbane, 2021.
He has served as a primary supervisor of four PhD students (two ongoings, two theses awarded) and co-supervisor of 23 PhD students in the medicinal chemistry, biotechnology, and vaccine development fields. All his former students have successfully found jobs, many of which are in the fields of biology or chemistry, across industry and academia, in Australia and abroad. Some notable examples of current employers of his past students include Harvard T.H. Chan School of Public Health, National University of Malaysia, The Translational Research Institute, Griffith University, Miltenyi Biotec Australia, James Cook University, Procter & Gamble, Woolcock Institute of Medical Research, WuXi Biologics, and Endologix California.
Works
Search Professor Mariusz Skwarczynski’s works on UQ eSpace
2014
Journal Article
Lipid core peptide targeting the cathepsin D hemoglobinase of Schistosoma mansoni as a component of a schistosomiasis vaccine
Dougall, Annette M., Skwarczynski, Mariusz, Khoshnejad, Makan, Chandrudu, Saranya, Daly, Norelle L., Toth, Istvan and Loukas, Alex (2014). Lipid core peptide targeting the cathepsin D hemoglobinase of Schistosoma mansoni as a component of a schistosomiasis vaccine. Human Vaccines and Immunotherapeutics, 10 (2), 399-409. doi: 10.4161/hv.27057
2014
Journal Article
The immune system likes nanotechnology
Toth, Istvan and Skwarczynski, Mariusz (2014). The immune system likes nanotechnology. Nanomedicine, 9 (17), 2607-2609. doi: 10.2217/nnm.14.199
2014
Conference Publication
Synthesis of therapeutic vaccine against cervical cancer
Skwarczynski, Mariusz, Liu, Tzu-Yu, Hussein, Waleed M., Jia, Zhongfan, Ziora, Zyta M., McMillan, Nigel A. J., Monteiro, Michael J. and Toth, Istvan (2014). Synthesis of therapeutic vaccine against cervical cancer. 4th Asia-Pacific International Peptide Symposium in conjunction with 50th Japanese Peptide Symposium, Osaka, Japan, 6-8 November 2013. Osaka, Japan: Japanese Peptide Society.
2014
Journal Article
Self-assembled peptide-polymer conjugates as vaccines
Liu, Tzu-Yu, Fuaad, Abdullah Al-Hadi Ahmad, Toth, Istvan and Skwarczynski, Mariusz (2014). Self-assembled peptide-polymer conjugates as vaccines. Chimica Oggi - Chemistry Today, 32 (2 (Supplement)), 18-22.
2014
Journal Article
Polymer–peptide hybrids as a highly immunogenic single-dose nanovaccine
Ahmad Fuaad, Abdullah A. H., Jia, Zhongfan, Hartas, Jon, Ziora, Zyta M., Lin, I-Chun, Moyle, Peter M., Batzloff, Michael R., Good, Michael F., Monteiro, Michael J., Skwarczynski, Mariusz and Toth, Istvan (2014). Polymer–peptide hybrids as a highly immunogenic single-dose nanovaccine. Nanomedicine, 9 (1), 35-43. doi: 10.2217/NNM.13.7
2013
Journal Article
Feherje alapu vedooltasok nanotechnologiaval
Toth, Istvan, Zaman, Mehfuz and Skwarczynski, Mariusz (2013). Feherje alapu vedooltasok nanotechnologiaval. Termézet Világa, 144 (11), 504-508.
2013
Journal Article
Self-adjuvanting polymer-peptide conjugates as therapeutic vaccine candidates against cervical cancer
Liu, Tzu-Yu, Hussein, Waleed M., Jia, Zhongfan, Ziora, Zyta M., McMillan, Nigel A. J., Monteiro, Michael J., Toth, Istvan and Skwarczynski, Mariusz (2013). Self-adjuvanting polymer-peptide conjugates as therapeutic vaccine candidates against cervical cancer. Biomacromolecules, 14 (8), 2798-2806. doi: 10.1021/bm400626w
2013
Journal Article
pH-Triggered peptide self-assembly into fibrils: a potential peptide-based subunit vaccine delivery platform
Skwarczynski, Mariusz, Kowapradit, Jariya, Ziora, Zyta Maria and Toth, Istvan (2013). pH-Triggered peptide self-assembly into fibrils: a potential peptide-based subunit vaccine delivery platform. Biochemical Compounds, 1. doi: 10.7243/2052-9341-1-2
2013
Journal Article
M-protein-derived conformational peptide epitope vaccine candidate against Group A Streptococcus
Skwarczynski, Mariusz, Kamaruzaman, Khairul A., Srinivasan, Saranya, Zaman, Mehfuz, Lin, I-Chun, Batzloff, Michael R., Good, Michael F. and Toth, Istvan (2013). M-protein-derived conformational peptide epitope vaccine candidate against Group A Streptococcus. Current Drug Delivery, 10 (1), 39-45. doi: 10.2174/1567201811310010007
2013
Journal Article
Liposome-based delivery system for vaccine candidates: constructing an effective formulation (vol 7, pg 1877, 2012)
Giddam, Ashwini Kumar, Zaman, Mehfuz, Skwarczynski, Mariusz and Toth, Istvan (2013). Liposome-based delivery system for vaccine candidates: constructing an effective formulation (vol 7, pg 1877, 2012). Nanomedicine, 8 (2), 312-312. doi: 10.2217/nnm.13.0
2013
Book Chapter
Lipo-peptides/saccharides in peptide vaccine delivery
Skwarczynskim, Mariusz, Zaman, Mehfuz and Toth, Istvan (2013). Lipo-peptides/saccharides in peptide vaccine delivery. Handbook of biologically active peptides. (pp. 571-579) edited by Abba J. Kastin. Amsterdam, Netherlands: Academic Press/Elsevier. doi: 10.1016/B978-0-12-385095-9.00078-6
2013
Journal Article
Microwave-assisted synthesis of difficult sequence-containing peptides using the isopeptide method
Hussein, Waleed M., Liu, Tzu-Yu, Toth, Istvan and Skwarczynski, Mariusz (2013). Microwave-assisted synthesis of difficult sequence-containing peptides using the isopeptide method. Organic and Biomolecular Chemistry, 11 (14), 2370-2376. doi: 10.1039/c3ob00030c
2013
Journal Article
Peptide conjugation via CuAAC 'click' chemistry
Ahmad Fuaad, Abdullah A. H., Azmi, Fazren, Skwarczynski, Mariusz and Toth, Istvan (2013). Peptide conjugation via CuAAC 'click' chemistry. Molecules, 18 (11), 13148-13174. doi: 10.3390/molecules181113148
2012
Journal Article
Liposome-based delivery system for vaccine candidates: constructing an effective formulation
Giddam, Ashwin Kumar, Zaman, Mehfuz, Skwarczynski, Mariusz and Toth, Istvan (2012). Liposome-based delivery system for vaccine candidates: constructing an effective formulation. Nanomedicine, 7 (12), 1877-1893. doi: 10.2217/nnm.12.157
2012
Journal Article
Peptide-Based Subunit Vaccine against Hookworm Infection
Skwarczynski, Mariusz, Dougall, Annette M., Khoshnejad, Makan, Chandrudu, Saranya, Pearson, Mark S., Loukas, Alex and Toth, Istvan (2012). Peptide-Based Subunit Vaccine against Hookworm Infection. PLoS One, 7 (10 Article #e46870) e46870, e46870. doi: 10.1371/journal.pone.0046870
2012
Journal Article
Vaccination with lipid core peptides fails to induce epitope-specific T cell responses but confers non-specific protective immunity in a malaria model.
Apte, Simon H., Groves, Penny L., Skwarczynski, Mariusz, Fujita, Yoshio, Chang, Chenghung, Toth, Istvan and Doolan, Denise L. (2012). Vaccination with lipid core peptides fails to induce epitope-specific T cell responses but confers non-specific protective immunity in a malaria model.. PLoS One, 7 (8 Article. No.e40928) e40928, e40928. doi: 10.1371/journal.pone.0040928
2012
Journal Article
Advances in peptide-based Human papillomavirus therapeutic vaccines
Liu, Tzu-Yu, Hussein, Waleed M., Toth, Istvan and Skwarczynski, Mariusz (2012). Advances in peptide-based Human papillomavirus therapeutic vaccines. Current Topics in Medicinal Chemistry, 12 (14), 1581-1592. doi: 10.2174/156802612802652402
2012
Journal Article
ChemInform Abstract: Medicinal Chemistry of α-Hydroxy-β-amino Acids
Ziora, Zyta, Skwarczynski, Mariusz and Kiso, Yoshiaki (2012). ChemInform Abstract: Medicinal Chemistry of α-Hydroxy-β-amino Acids. ChemInform, 43 (25), no-no. doi: 10.1002/chin.201225259
2012
Journal Article
Lipopeptides for the fragment-based pharmaceutics design
Ziora, Zyta M., Wimmer, Norbert, New, Roger, Skwarczynski, Mariusz and Toth, Istvan (2012). Lipopeptides for the fragment-based pharmaceutics design. International Journal of Organic Chemistry, 2 (01), 75-81. doi: 10.4236/ijoc.2012.21013
2012
Conference Publication
Nanoparticles-based peptide subunit vaccines against group A Streptococcus
Skwarczynski, M., Fuaad, A. A. H. A., Zaman, M., Jia, Z., Kowapradit, J., Rustanti, L., Ziora, Z. M., Monteiro, M. L. J., Batzloff, M. R., Goodc, M. F. and Toth, I. (2012). Nanoparticles-based peptide subunit vaccines against group A Streptococcus. 32nd European Peptide Symposium, Athens, Greece, 2-7 September 2012. Chichester, West Sussex, United Kingdom: John Wiley & Sons. doi: 10.1002/psc.2448
Funding
Current funding
Past funding
Supervision
Availability
- Associate Professor Mariusz Skwarczynski is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
Polymers and peptides for vaccine delivery.
Principal Advisor
Other advisors: Emeritus Professor Istvan Toth
-
Doctor Philosophy
Development of silver nanoparticles as novel adjuvants in vaccine
Principal Advisor
Other advisors: Emeritus Professor Istvan Toth
-
Doctor Philosophy
Poly(hydrophobic amino acids) as immune stimulators.
Principal Advisor
Other advisors: Emeritus Professor Istvan Toth
-
Doctor Philosophy
Poly(hydrophobic amino acids) as immune stimulators.
Principal Advisor
Other advisors: Emeritus Professor Istvan Toth
-
Doctor Philosophy
Hookworm vaccine: vaccine development toward clinical trials
Principal Advisor
Other advisors: Emeritus Professor Istvan Toth
-
Doctor Philosophy
Polymers and peptides for vaccine delivery.
Principal Advisor
-
Doctor Philosophy
Poly(hydrophobic amino acids) as immune stimulators.
Principal Advisor
Other advisors: Emeritus Professor Istvan Toth
-
Doctor Philosophy
L-Rhamnose-based nanovaccine derived from poly-rhamnose backbone of Group A Carbohydrate (GAC) against Invasive Group A Streptococcus and Rheumatic Heart Disease
Principal Advisor
Other advisors: Emeritus Professor Istvan Toth
-
Doctor Philosophy
Delivery systems for novel vaccine candidates against infectious diseases
Associate Advisor
Other advisors: Dr Jazmina Gonzalez Cruz
-
Doctor Philosophy
Development of poly(hydrophobic amino acids)-based immunopotentiators for subunit vaccines against infectious diseases
Associate Advisor
Other advisors: Dr Jazmina Gonzalez Cruz
-
Doctor Philosophy
Development of poly(hydrophobic amino acids)-based immunopotentiators for subunit vaccines against infectious diseases
Associate Advisor
Other advisors: Dr Jazmina Gonzalez Cruz
-
Doctor Philosophy
Novel Vaccine Designs of Adjuvants and Delivery Systems against Infectious Diseases
Associate Advisor
Other advisors: Emeritus Professor Istvan Toth, Dr Rachel Stephenson
-
Doctor Philosophy
A nanovaccine against Invasive Group A Streptococcus and Rheumatic Heart Disease
Associate Advisor
Other advisors: Dr Rachel Stephenson, Emeritus Professor Istvan Toth
Completed supervision
-
2022
Doctor Philosophy
Development of a new peptide-based self-adjuvanting delivery system for vaccine against Group A Streptococcus (GAS)
Principal Advisor
Other advisors: Emeritus Professor Istvan Toth
-
2022
Doctor Philosophy
Delivery of a peptide-based vaccine against group A streptococcus with the help of cell-penetrating peptides
Principal Advisor
Other advisors: Emeritus Professor Istvan Toth
-
2025
Doctor Philosophy
Development of poly(hydrophobic amino acids)-based immunopotentiators for subunit vaccines against infectious diseases
Associate Advisor
Other advisors: Dr Jazmina Gonzalez Cruz, Emeritus Professor Istvan Toth
-
2023
Doctor Philosophy
Polymers as a nanoparticulate adjuvant and vaccine delivery system
Associate Advisor
Other advisors: Emeritus Professor Istvan Toth
-
2023
Doctor Philosophy
Lipophilic Peptides as Immune Stimulants
Associate Advisor
Other advisors: Emeritus Professor Istvan Toth
-
2023
Doctor Philosophy
The role of shape in vaccine delivery: Polymeric nanoparticles-based peptide vaccine against Group A Streptococci (GAS) infection
Associate Advisor
Other advisors: Emeritus Professor Istvan Toth
-
2023
Doctor Philosophy
Cholesterol-based Vaccine Delivery Systems against Group A Streptococcal Infection
Associate Advisor
Other advisors: Emeritus Professor Istvan Toth
-
2023
Doctor Philosophy
Development of Peptide-based Vaccines against Infectious Diseases: Hookworm, Liver fluke, and SARS-CoV-2 virus
Associate Advisor
Other advisors: Dr Waleed Hussein, Emeritus Professor Istvan Toth
-
2022
Doctor Philosophy
Targeting lectin receptors for vaccine delivery against group A streptococcus
Associate Advisor
Other advisors: Emeritus Professor Istvan Toth
-
2022
Doctor Philosophy
Development of polyacrylate-based delivery systems for peptide vaccines
Associate Advisor
Other advisors: Emeritus Professor Istvan Toth
-
2022
Doctor Philosophy
Development of an effective prophylactic and therapeutic treatment for malaria
Associate Advisor
Other advisors: Emeritus Professor Istvan Toth
-
2020
Doctor Philosophy
Hydrophobic amino acid-based vaccine delivery systems to induce cellular and humoral immunity
Associate Advisor
Other advisors: Emeritus Professor Istvan Toth
-
2020
Doctor Philosophy
Design and evaluation of polysaccharide-based nanoparticles for mucosal vaccine delivery
Associate Advisor
Other advisors: Dr Waleed Hussein, Emeritus Professor Istvan Toth
-
2019
Doctor Philosophy
Development of novel nanoparticulate polymeric delivery system for peptide vaccines against group A streptococcus
Associate Advisor
Other advisors: Emeritus Professor Istvan Toth
-
2018
Doctor Philosophy
Peptide-Based Self-Assembling Delivery System for Development of Group A Streptococcus Vaccine
Associate Advisor
Other advisors: Emeritus Professor Istvan Toth
-
2018
Doctor Philosophy
Epitope-focused vaccines against respiratory syncytial virus
Associate Advisor
Other advisors: Professor Keith Chappell, Professor Daniel Watterson, Emeritus Professor Istvan Toth
-
2017
Doctor Philosophy
Development of novel nanoparticle-based mucosal delivery systems for lipopeptide vaccine against group A streptococcus
Associate Advisor
Other advisors: Emeritus Professor Istvan Toth
-
2016
Doctor Philosophy
Liposome-based delivery system for the development of malaria vaccine
Associate Advisor
Other advisors: Emeritus Professor Istvan Toth
-
2016
Doctor Philosophy
Development of Peptide-Based Vaccines Against Group A Streptococcus (GAS) and Malaria
Associate Advisor
Other advisors: Emeritus Professor Istvan Toth
-
2016
Doctor Philosophy
Therapeutic and Preventive Potential of Synthetic Lipopeptides against Bacterial Infections
Associate Advisor
Other advisors: Emeritus Professor Istvan Toth
-
2016
Doctor Philosophy
Development of Novel Strategies for Delivery of Vaccine Candidates Against Group A Streptococcus
Associate Advisor
Other advisors: Emeritus Professor Istvan Toth, Dr Waleed Hussein
-
2015
Doctor Philosophy
The Development of Peptide-Based Subunit Vaccines against Streptococcus pyogenes, Necator americanus and Schistosome mansoni.
Associate Advisor
Other advisors: Emeritus Professor Istvan Toth
-
2015
Doctor Philosophy
Self-assembling and self-adjuvanting polymer-peptide conjugates as therapeutic vaccines against cervical cancer
Associate Advisor
Other advisors: Emeritus Professor Istvan Toth
-
2010
Doctor Philosophy
Lipopeptide-Carbohydrate-Antigen Platforms for Synthetic Vaccine Development
Associate Advisor
Other advisors: Emeritus Professor Istvan Toth
-
2010
Doctor Philosophy
The synthesis and characterization of peptide-based carriers for gene delivery and peptide therapeutics
Associate Advisor
Other advisors: Emeritus Professor Istvan Toth
Media
Enquiries
Contact Associate Professor Mariusz Skwarczynski directly for media enquiries about:
- fertility control
- group A streptococcus
- hookworm
- immune adjuvants
- nanovaccines
- peptide vaccines
Need help?
For help with finding experts, story ideas and media enquiries, contact our Media team: